ArticlePharmaceuticals (Basel, Switzerland)2025

TAIII Suppresses the Growth of T790M-Mutant Non-Small-Cell Lung Cancer by Targeting the EGFR/ERK Signaling Pathway.

Shang Gao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.